Abingdon, United Kingdom

Mohamad Sabbah

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Evotec International Gmbh. Active years: 2025-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.8

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mohamad Sabbah: Innovator in Integrated Stress Response Pathway Modulators

Introduction

Mohamad Sabbah is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate the integrated stress response pathway. His work is crucial for advancing treatments for various diseases and disorders.

Latest Patents

Mohamad Sabbah holds a patent for "Modulators of the integrated stress response pathway." This invention relates to compounds of formula (I) or pharmaceutically acceptable salts, solvates, hydrates, tautomers, or stereoisomers thereof. The patent outlines the use of these compounds in pharmaceutical compositions and their application as medicaments for treating and preventing diseases associated with the integrated stress response.

Career Highlights

Sabbah is currently employed at Evotec International GmbH, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic strategies that leverage the integrated stress response pathway to combat various health issues.

Collaborations

Some of his notable coworkers include Holly Atton and Christopher John Brown. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Mohamad Sabbah's contributions to the pharmaceutical industry, particularly through his patent on integrated stress response pathway modulators, highlight his role as an influential inventor. His ongoing work at Evotec International GmbH promises to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…